IP Library › Granted Patent US 11,331,018
Granted Patent B2
US 11,331,018 · App. 15/852,885 · Granted May 17, 2022

System and single-channel biosensor for and method of determining analyte value

Inventors: Brad Rice (South San Francisco, CA); Soya Gamsey (San Francisco, CA); William A. McMillan (La Honda, CA)
Assignee: Profusa, Inc.
A61B5/14556A61B5/1459A61B5/14532A61B5/14539A61B5/14546A61B2562/0238
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,331,018
App. No.
15/852,885
Granted
May 17, 2022
Kind
B2
Abstract

Some embodiments described herein relate to a sensor that includes an analyte-sensing dye and a reference dye. The analyte-sensing dye can be configured to emit an analyte-dependent optical signal in the presence of an analyte. Similarly stated, the intensity and/or duration of the analyte-dependent optical signal can be modulated by a quantity and/or concentration of the analyte in the environment of the sensor. The reference dye can be configured to emit an analyte-independent optical signal. The analyte-dependent optical signal and the analyte-independent optical signal have an analyte-dependent spectrum and an analyte-independent spectrum, respectfully. The analyte-dependent optical spectrum and the analyte-independent spectrum can be the same, substantially the same, and/or overlapping. The analyte-dependent optical signal can have a duration of lifetime that is shorter than a duration or lifetime of the analyte-independent optical signal.

Claims (43)

1. A system, comprising:

a sensor, including:

an analyte-sensing dye configured to emit an analyte-dependent optical signal in the presence of an analyte, the analyte-dependent optical signal having an analyte-dependent spectrum and a first duration; and

a reference dye configured to emit an analyte-independent optical signal having an analyte-independent spectrum and a second duration, the analyte-dependent spectrum and the analyte-independent spectrum overlapping, the second duration exceeding the first duration; and

a reader, including:

a light source configured to emit an illumination signal configured to excite the analyte-sensing dye and the reference dye, the analyte-sensing dye and the reference dye configured to emit the analyte-dependent optical signal and the analyte-independent optical signal, respectively, in response to being excited by the illumination signal;

a detector configured to detect the analyte-dependent optical signal and the analyte-independent optical signal;

an amplifier having variable gain, the amplifier configured to process a signal received during a first time period that is associated with the analyte-dependent optical signal with a first gain to produce a first processed signal, the amplifier configured to process a signal received during a second time period that is associated with the analyte-independent signal with a second gain different from the first gain to produce a second processed signal, the second time period being after the first time period; and

a processor configured to determine at least one of a concentration or a quantity of the analyte based on a ratio of the first processed signal and the second processed signal.

2. The system of claim 1 , wherein the illumination signal has a spectrum configured to simultaneously excite the analyte-sensing dye and the reference dye.

3. The system of claim 1 , wherein the light source is a single light source configured to emit a single illumination signal configured to simultaneously excite the analyte-sensing dye and the reference dye.

4. The system of claim 1 , wherein the detector is a single detector configured to detect each of the analyte-dependent optical signal and the analyte-independent optical signal.

5. The system of claim 1 , wherein:

the sensor is configured to be implanted in tissue of a body; and

the reader is configured to be disposed outside the body, the sensor and the reader not being physically coupled.

6. The system of claim 1 , wherein the reader includes a filter disposed between the light source and the sensor, all light emitted from the reader passing through the filter.

7. The system of claim 1 , wherein the reader includes a filter disposed between the detector and the sensor, all light entering the reader passing through the filter.

8. The system of claim 1 , wherein the second duration is at least an order of magnitude greater than the first duration.

9. The system of claim 1 , wherein the reference dye is configured to emit the analyte-independent optical signal with an intensity that is insensitive to a chemical environment in which the reference dye is disposed.

10. The system of claim 1 , wherein the first duration is less than 50 nanoseconds.

11. The system of claim 1 , wherein the second duration is greater than 1 microsecond.

12. The system of claim 1 , wherein:

the first duration is less than 50 nanoseconds; and

the second duration is greater than 1 microsecond.

13. The system of claim 1 , wherein the analyte is at least one of oxygen, glucose, lactate, carbon dioxide, H + , or OH − .

14. The system of claim 1 , wherein:

the analyte-sensing dye is a first analyte-sensing dye configured to emit a first analyte-dependent optical signal in the presence of a first analyte; and

the analyte-dependent optical signal is a first analyte-dependent optical signal having a first analyte-dependent spectrum, the system further comprising:

a second analyte-sensing dye configured to emit a second analyte-dependent optical signal in the presence of a second analyte, the second analyte-dependent optical signal having a second analyte-dependent spectrum different from the first analyte-dependent spectrum.

15. The system of claim 1 , wherein the sensor is configured to be implanted in tissue of a body.

16. The system of claim 1 , wherein:

the sensor is configured to be implanted in tissue of a body; and

the analyte-sensing dye is configured to emit the analyte-dependent optical signal in the presence of the analyte within blood or interstitial fluid of the tissue.

17. A method, comprising:

illuminating a sensor with an illumination signal to simultaneously excite an analyte-dependent dye and an analyte-independent dye such that the analyte-dependent dye emits an analyte-dependent optical signal having a first duration simultaneously with the analyte-independent dye emitting an analyte-independent optical signal having a second duration longer than the first duration, a spectrum of the analyte-independent optical signal overlapping a spectrum of the analyte-dependent optical signal;

detecting the analyte-dependent optical signal during a first time period;

processing a signal associated with the analyte-dependent optical signal with an amplifier at a first gain;

detecting an analyte-independent optical signal during a second time period after the first time period;

processing a signal associated with the analyte-independent optical signal with the amplifier at a second gain higher than the first gain; and

determining at least one of a quantity or a concentration of an analyte based on a ratio of the signal associated with the analyte-dependent optical signal processed with the first gain and the signal associated with the analyte-independent optical signal processed with the second gain.

18. The method of claim 17 , wherein the illumination signal is emitted from is a single light source configured to emit a single illumination signal configured to simultaneously excite the analyte-sensing dye and the reference dye.

19. The method of claim 17 , wherein a spectrum of the analyte-dependent optical signal is the same as a spectrum of the analyte-independent optical signal.

20. The method of claim 17 , wherein the analyte-dependent optical signal and the analyte-independent optical signal are detected by the same detector.

Assignments (2)
LIEN Recorded Jul 21, 2025
From: PROFUSA, INC.
To: ASCENT PARTNERS FUND, LLC
Reel/Frame 071773/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2018
From: RICE, BRAD; GAMSEY, SOYA; MCMILLAN, WILLIAM A.
To: PROFUSA, INC.
Reel/Frame 044525/0397 →
Continuity (2)
Provisional Application 62438113 · Dec 22, 2016
Related Publication 20180177443A1 · Jun 28, 2018
Cited By (1)
US 12,727,793